EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Mesenchymal stem cell‐mediated mitochondrial transfer regulates the fate of B lymphocytes

Veronika Somova, Natalie Jaborova, Bianka Porubska, Daniel Vasek, Natalie Fikarova, Martin Prevorovsky, Zuzana Nahacka, Jiri Neuzil, Magdalena Krulova iD

European Journal of Clinical Investigation · 2025

DOI: 10.1111/eci.70073 ↗

At a glance

Journal article in European Journal of Clinical Investigation, 2025. Written by Veronika Somova and 8 co-authors. Institution: Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic. Major MEDLINE topics: B-Lymphocytes, Mesenchymal Stem Cells, Mitochondria. Cited 15 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: Univerzita Karlova v Praze, Grantová Agentura České Republiky, Grantová Agentura, Univerzita Karlova.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Mitochondrial transfer is becoming recognized as an important immunomodulatory mechanism used by mesenchymal stem cells (MSCs) to influence immune cells. While effects on T cells and macrophages have been documented, the influence on B cells remains unexplored. This study investigates the modulation of B lymphocyte fate by MSC‐mediated mitochondrial transfer.

Methods

MSCs labelled with MitoTracker dyes or derived from mito::mKate2 transgenic mice were co‐cultured with splenocytes. Flow cytometry assessed mitochondrial transfer, reactive oxygen species (ROS) levels, apoptosis and mitophagy. Glucose uptake was measured using the 2‐NBDG assay. RNA sequencing analysed gene expression changes in CD19+ mitochondria recipients and nonrecipients. Pathway analysis identified affected processes. In an LPS‐induced inflammation model, mito::mKate2 MSCs were administered, and B cells from different organs were analysed for mitochondrial uptake and phenotypic changes. MSC‐derived mitochondria were also isolated to confirm uptake by FACS‐sorted CD19+ cells.

Results

MSCs transferred mitochondria to CD19+ cells, though less than to other immune cells. Transfer correlated with ROS levels and mitophagy induction. Mitochondria were preferentially acquired by activated B cells, as indicated by increased CD69 expression and glycolytic activity. Bidirectional transfer occurred, with immune cells exchanging dysfunctional mitochondria for functional ones. CD19+ recipients exhibited increased viability, proliferation and altered gene expression, with upregulated cell division genes and downregulated antigen presentation genes. In vivo, mitochondrial acquisition reduced B cell activation and inflammatory cytokine production. Pre‐sorted B cells also acquired isolated mitochondria, exhibiting a similar anti‐inflammatory phenotype.

Conclusions

These findings highlight mitochondrial trafficking as a key MSC‐immune cell interaction mechanism with immunomodulatory therapeutic potential.

Subjects

MeSH terms (MEDLINE)

B-LymphocytesMesenchymal Stem CellsMitochondriaAnimalsReactive Oxygen SpeciesMitophagyMiceAntigens, CD19Mice, TransgenicApoptosisSpleenLymphocyte ActivationCoculture TechniquesAntigens, Differentiation, T-LymphocyteAntigens, CDLectins, C-TypeCD69 Antigens

Author keywords

B cellimmunoregulationmesenchymal stem cellmetabolismmitochondria

Substances

Reactive Oxygen SpeciesAntigens, CD19Antigens, Differentiation, T-LymphocyteAntigens, CDLectins, C-TypeCD69 Antigens

Authors and institutions

  • Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic.
  • Laboratory of Molecular Therapy, Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic.
  • Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic.
  • School of Pharmacy and Medical Science, Griffith University, Southport, Queensland, Australia.
  • First Faculty of Medicine, Charles University, Prague, Czech Republic.

ORCID profiles: Magdalena Krulova

Funding

  • Univerzita Karlova v Praze
  • Grantová Agentura České Republiky
  • Grantová Agentura, Univerzita Karlova

Cite

APA

Somova, V., Jaborova, N., Porubska, B., Vasek, D., Fikarova, N., Prevorovsky, M., Nahacka, Z., Neuzil, J., & Krulova, M. (2025). Mesenchymal stem cell‐mediated mitochondrial transfer regulates the fate of B lymphocytes. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70073

Vancouver

Somova V, Jaborova N, Porubska B, Vasek D, Fikarova N, Prevorovsky M, et al. Mesenchymal stem cell‐mediated mitochondrial transfer regulates the fate of B lymphocytes. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.70073

BibTeX
@article{Somova2025,
  author = {Somova, Veronika and Jaborova, Natalie and Porubska, Bianka and Vasek, Daniel and Fikarova, Natalie and Prevorovsky, Martin and Nahacka, Zuzana and Neuzil, Jiri and Krulova, Magdalena},
  title = {Mesenchymal stem cell‐mediated mitochondrial transfer regulates the fate of B lymphocytes},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1111/eci.70073}
}
Start for free →